38 Results

People

  1. Bertino
    Bertino
  2. Lee
    Lee
  3. Majumdar
    Majumdar
  4. Saltz
    Saltz
  5. Corless
    Corless
  6. Finn
    Finn
  7. Fong
    Fong
  8. Gardner
    Gardner
  9. Hudis
    Hudis
  10. Larson
    Larson

Groups

  1. GSK Faculty (12)
  2. Department of Medicine (11)
  3. Molecular Pharmacology and Chemistry Program Faculty (10)
  4. Sloan Kettering Institute Faculty (10)
  5. Solid Tumor Oncology Division (8)
  6. Radiology, Department of (6)
  7. Sloan Kettering Institute Postdocs (6)
  8. Surgery (6)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  10. Breast Medicine Service (4)
  1. "prodrug"
Formats
  1. Journal Article (37)
  2. Research Letter (1)
Groups
  1. GSK Faculty (12)
  2. Department of Medicine (11)
  3. Molecular Pharmacology and Chemistry Program Faculty (10)
  4. Sloan Kettering Institute Faculty (10)
  5. Solid Tumor Oncology Division (8)
  6. Radiology, Department of (6)

More Groups

People
  1. Joseph Bertino (4)
  2. Jonghan Lee (3)
  3. Leonard Saltz (3)
  4. Susruta Majumdar (3)
  5. Broderick Corless (2)
  6. Clifford Hudis (2)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (1)
  5. 2020 (1)
  6. 2019 (1)

More Years

Publications
  1. Clinical Cancer Research (3)
  2. Journal of Nuclear Medicine (3)
  3. Journal of Clinical Oncology (2)
  4. Molecular Cancer Therapeutics (2)
  5. Molecules (2)
  6. ACS Medicinal Chemistry Letters (1)

More Publications

Publishers
  1. American Association for Cancer Research (5)
  2. Elsevier Inc. (4)
  3. Nature Publishing Group (4)
  4. Society of Nuclear Medicine (3)
  5. American Chemical Society (2)
  6. American Society of Clinical Oncology (2)

More Publishers

Results (38)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • mTORC1 regulates the pyrimidine salvage pathway by controlling UCK2 turnover via the CTLH-WDR26 E3 ligase
    Journal Article

    Pham, B. Q.; Yi, S. A.; Ordureau, A.; An, H.
    Cell Reports (2025)

    Fulltext@MSK | Save
  • Gliocidin is a nicotinamide-mimetic prodrug that targets glioblastoma
    Journal Article

    Chen, Y. J.; Iyer, S. V.; Hsieh, D. C. C.; Li, B.; Elias, H. K.; Wang, T.; Li, J.; Ganbold, M.; Lien, M. C.; Peng, Y. C.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • ROS-activatable prodrug of doxazolidine as novel cancer therapy paradigm
    Journal Article

    Tamura, R.; Carpenter, C. I.; Thomas, C. M.; Kamyabi, G.; Hsu, H. T.; Vergnolle, O.; Balderes, P.; Grimm, J.
    Advanced Therapeutics (2024)

    Fulltext@MSK | Save
  • Development of a p-hydroxybenzyl-alcohol-linked glutamate prodrug for activation by pseudomonas carboxypeptidase G2
    Journal Article

    Lee, J. P.; Corless, B. C.; Gardner, T. J.; Scheinberg, D. A.; Tan, D. S.
    Organic Letters (2023)

    Fulltext@MSK | Save
  • Targeting carbohydrate mimetics of tetrahydrofuran-containing acetogenins to prostate cancer
    Journal Article

    Periche, P. G.; Lin, J.; Bhupathiraju, N. V. S. D. K.; Kalidindi, T.; Johnson, D. S.; Pillarsetty, N.; Mootoo, D. R.
    Molecules (2023)

    Fulltext@MSK | Save
  • Engineering CAR-T cells to activate small-molecule drugs in situ
    Journal Article

    Gardner, T. J.; Lee, J. P.; Bourne, C. M.; Wijewarnasuriya, D.; Kinarivala, N.; Kurtz, K. G.; Corless, B. C.; Dacek, M. M.; Chang, A. Y.; Mo, G.; more...
    Nature Chemical Biology (2022)

    Fulltext@MSK | Save
  • Brain permeable tafamidis amide analogs for stabilizing TTR and reducing APP cleavage
    Research Letter

    Sinha, A.; Chang, J. C.; Xu, P.; Gindinova, K.; Cho, Y.; Sun, W.; Wu, X.; Li, Y. M.; Greengard, P.; Kelly, J. W.; more...
    ACS Medicinal Chemistry Letters (2020)

    Fulltext@MSK | Save
  • A chemical probe of CARM1 alters epigenetic plasticity against breast cancer cell invasion
    Journal Article

    Cai, X. C.; Zhang, T.; Kim, E. J.; Jiang, M.; Wang, K.; Wang, J.; Chen, S.; Zhang, N.; Wu, H.; Li, F.; more...
    eLife (2019)

    Fulltext@MSK | Save
  • PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma
    Journal Article

    Abou-Alfa, G. K.; Chan, S. L.; Lin, C. C.; Chiorean, E. G.; Holcombe, R. F.; Mulcahy, M. F.; Carter, W. D.; Patel, K.; Wilson, W. R.; Melink, T. J.; more...
    Cancer Chemotherapy and Pharmacology (2011)

    Fulltext@MSK | Save
  • Antitumor activity of SNX-2112, a synthetic heat shock protein-90 inhibitor, in Met-amplified tumor cells with or without resistance to selective MET inhibition
    Journal Article

    Bachleitner-Hofmann, T.; Sun, M. Y.; Chen, C. T.; Liska, D.; Zeng, Z.; Viale, A.; Olshen, A. B.; Mittlboeck, M.; Christensen, J. G.; Rosen, N.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save